Prolonged survival in patients with beta-thalassemia major treated with deferoxamine
- 30 April 1991
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 118 (4) , 540-545
- https://doi.org/10.1016/s0022-3476(05)83374-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Bone Marrow Transplantation in Patients with ThalassemiaNew England Journal of Medicine, 1990
- A Prospective Evaluation of Iron Chelation Therapy in Children With Severe β-ThalassemiaAmerican Journal of Diseases of Children, 1988
- Current Strategies in the Management of Cooley's AnemiaaAnnals of the New York Academy of Sciences, 1985
- Chelation therapy in β-thalassemia major. III. The role of splenectomy in achieving iron balanceThe Journal of Pediatrics, 1981
- LONGITUDINAL STUDY OF CARDIAC FUNCTION IN THALASSEMIA MAJOR *Annals of the New York Academy of Sciences, 1980
- New approaches to the transfusion management of thalassemiaBlood, 1980
- IMPROVEMENT IN IRON STATUS AND LIVER FUNCTION IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD WITH LONG-TERM SUBCUTANEOUS DESFERRIOXAMINEThe Lancet, 1979
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977
- Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical ProgressBMJ, 1974
- Late Cardiac Complications of Chronic, Severe, Refractory Anemia with HemochromatosisCirculation, 1964